Egyptian International Pharmaceutical Industries Company Share Price
Stocks
PHAR
EGS38081C013
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.60 EGP | 0.00% |
|
+2.69% | +11.74% |
| 05-17 | Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-17 | EIPICO Q1 consol profit EGP 284 million | RE |
| Capitalization | 14.61B 281M 243M 224M 210M 392M 26.9B 399M 2.65B 1.03B 12.95B 1.06B 1.03B 45.01B | P/E ratio 2024 |
6.23x | P/E ratio 2025 | 8.71x |
|---|---|---|---|---|---|
| Enterprise value | 21.99B 423M 366M 337M 317M 590M 40.47B 600M 3.99B 1.55B 19.49B 1.59B 1.55B 67.74B | EV / Sales 2024 |
1.94x | EV / Sales 2025 | 2.17x |
| Free-Float |
35.11% | Yield 2024 |
3.27% | Yield 2025 | - |
| 1 week | +2.69% | ||
| Current month | +2.69% | ||
| 1 month | -0.92% | ||
| 3 months | +9.38% | ||
| 6 months | +22.94% | ||
| Current year | +11.74% |
| 1 week | 85.5 |  | 88.2 |
| 1 month | 83.96 | | 92.4 |
| Current year | 72.11 | | 92.4 |
| 1 year | 43.6 | | 92.4 |
| 3 years | 25.46 | | 92.4 |
| 5 years | 24.5 | | 92.4 |
| 10 years | 24.5 | | 122.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
Khaled Mahmoud
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Chairman | - | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +2.69% | +72.82% | +233.85% | 282M | |
| +0.37% | -0.58% | +6.53% | +76.31% | 44.87B | |
| -0.28% | -9.94% | +55.65% | +97.49% | 34.76B | |
| -0.96% | -0.94% | -7.73% | +44.51% | 11.88B | |
| -0.13% | +0.92% | +13.27% | +111.14% | 11.5B | |
| +0.39% | +0.79% | +36.90% | +126.55% | 8.92B | |
| +1.85% | -5.45% | +19.02% | +42.15% | 7.05B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +1.03% | -6.04% | +49.72% | -17.12% | 6.52B | |
| +0.48% | -4.33% | +36.87% | +228.26% | 6.41B | |
| Average | +0.28% | -2.84% | +31.45% | +104.79% | 13.9B | |
| Weighted average by Cap. | +0.15% | -3.52% | +25.21% | +86.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.59B 146M 126M 116M 109M 204M 13.97B 207M 1.38B 536M 6.73B 548M 536M 23.38B | 9.44B 182M 157M 145M 136M 253M 17.38B 258M 1.71B 667M 8.37B 682M 667M 29.08B |
| Net income | 1.1B 21.07M 18.25M 16.81M 15.78M 29.39M 2.02B 29.91M 199M 77.36M 971M 79.11M 77.4M 3.37B | 1.44B 27.72M 24.01M 22.12M 20.76M 38.67M 2.65B 39.36M 261M 102M 1.28B 104M 102M 4.44B |
| Net Debt | 7.93B 153M 132M 122M 114M 213M 14.6B 217M 1.44B 560M 7.03B 573M 560M 24.43B | 7.38B 142M 123M 113M 106M 198M 13.58B 201M 1.34B 521M 6.54B 533M 521M 22.73B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/06/26 | 86.60 £ | 0.00% | 84,351 |
| 07/06/26 | 86.60 £ | -1.59% | 343,774 |
| 04/06/26 | 88.00 £ | +1.31% | 731,477 |
| 03/06/26 | 86.86 £ | -0.07% | 97,904 |
| 02/06/26 | 86.92 £ | +0.49% | 476,377 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
86.60EGP
Average target price
100.00EGP
Spread / Average Target
+15.47%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PHAR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition